An Observational Monocentric Study Investigating the Association Between Trough Serum Levels of Etanercept, Antibodies Towards Etanercept and Its Effectiveness in Psoriasis Patients

Universitaire Ziekenhuizen KU Leuven56 enrolled

Overview

The purpose of this study is to investigate the association between trough serum levels of etanercept, antibodies towards etanercept and its effectiveness in psoriasis patients.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Psoriasis

Interventions

etanerceptDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age from 18 years on, male or female * Established diagnosis of psoriasis * Etanercept either on monotherapy or in combination with acitretin (Neotigason®), given according to the current EU SmPC including the safety measures. * Patients who give informed consent for this study

Outcomes

Primary Outcomes

trough serum etanercept concentration

Time frame: one year

anti-etanercept serum concentration

Time frame: one year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.